4//SEC Filing
Hagerty David T 4
Accession 0001209191-18-007556
CIK 0001383701other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:59 PM ET
Size
5.8 KB
Accession
0001209191-18-007556
Insider Transaction Report
Form 4
Hagerty David T
EVP, Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2018-02-04+70,000→ 70,000 totalExercise: $5.17Exp: 2028-02-03→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The option was granted on February 4, 2018. 25% of the total number of shares of common stock subject to the option will vest on February 2, 2019, and 1/48th of the total number of shares of common stock subject to the option will vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
Conatus Pharmaceuticals Inc.
CIK 0001383701
Entity typeother
Related Parties
1- filerCIK 0001513859
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:59 PM ET
- Size
- 5.8 KB